Loading...
CanaFarma Hemp Products Corp.
CNFA.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.05
CA$0.00(0.00%)

Financial performance has remained strong, with revenue growing from -$1.11M in Q4 2020 to $79497.00 in Q3 2021. Gross profit continued to perform well, with margins at 124% in the latest quarter. Operating income reached -$1.84M in Q3 2021, holding a steady -2310% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$1.78M. Net income rose to -$819762.00, keeping EPS at -$0.004. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan